PCNA mRNA expression manifestedlow cancer specificity, ranging from high concentrations in lymphomato moderate levels in gastric cancer and lower amounts in adrenocorticalcancers, indicating that it is abundantly expressed in multiple cancersrather than a single malignancy (Figure b), thereby rendering it a strong candidatefor prognostic biomarker. The gene discussed is PCNA; the disease is cancer.